Evidence map›Paper›PMID 20974805›Full record

ArticleMolecular and cellular biology2011

Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and function.

David P Harris, Peter Vogel, Marie Wims, Karen Moberg, Juliane Humphries, Kanchan G Jhaver, Christopher M DaCosta, Melanie K Shadoan, Nianhua Xu, Gwenn M Hansen and 4 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 59 citations in OpenAlex.

  1. Inactivation of PI3K-C2α deregulates cell death pathways and sensitizes to endotoxic shock.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Phosphoinositide 3-Kinases as Potential Targets for Thrombosis Prevention.International journal of molecular sciences · 2022
    Review
  5. Article
  6. PI3K Isoforms in B Cells.Current topics in microbiology and immunology · 2022
    Article
  7. UsingFrontiers in cell and developmental biology · 2022
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Journal of the American Society of Nephrology : JASN · 2019
    Article
  13. Review
  14. Review
  15. Review
  16. Phosphoinositides in the kidney.Journal of lipid research · 2019
    Review
  17. Journal of the American Society of Nephrology : JASN · 2018
    Article
  18. Podocyte-actin dynamics in health and disease.Nature reviews. Nephrology · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

David P HarrisLexicon Pharmaceuticals, Inc., 8800 Technology Forest Place, The Woodlands, TX 77381, USA. dpharris@lexpharma.com
Peter Vogel
Marie Wims
Karen Moberg
Juliane Humphries
Kanchan G Jhaver
Christopher M DaCosta
Melanie K Shadoan
Nianhua Xu
Gwenn M Hansen
Sanjeevi Balakrishnan
Jan Domin
David R Powell
Tamas Oravecz
Lexicon Pharmaceuticals (United States) · USImperial College London · GB

Funding

Medical Research Council G0500936
6 · The paper itself

Abstract

An early lesion in many kidney diseases is damage to podocytes, which are critical components of the glomerular filtration barrier. A number of proteins are essential for podocyte filtration function, but the signaling events contributing to development of nephrotic syndrome are not well defined. Here we show that class II phosphoinositide 3-kinase C2α (PI3KC2α) is expressed in podocytes and plays a critical role in maintaining normal renal homeostasis. PI3KC2α-deficient mice developed chronic renal failure and exhibited a range of kidney lesions, including glomerular crescent formation and renal tubule defects in early disease, which progressed to diffuse mesangial sclerosis, with reduced podocytes, widespread effacement of foot processes, and modest proteinuria. These findings were associated with altered expression of nephrin, synaptopodin, WT-1, and desmin, indicating that PI3KC2α deficiency specifically impacts podocyte morphology and function. Deposition of glomerular IgA was observed in knockout mice; importantly, however, the development of severe glomerulonephropathy preceded IgA production, indicating that nephropathy was not directly IgA mediated. PI3KC2α deficiency did not affect immune responses, and bone marrow transplantation studies also indicated that the glomerulonephropathy was not the direct consequence of an immune-mediated disease. Thus, PI3KC2α is critical for maintenance of normal glomerular structure and function by supporting normal podocyte function.

Indexed as

AnimalsAntigens, SurfaceBone Marrow TransplantationGlomerulonephritisGlomerulonephritis, IGAHumansImmunoglobulin AImmunoglobulin GKidney GlomerulusMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMicrofilament ProteinsPhosphatidylinositol 3-KinasesPodocytesAntigens, SurfaceImmunoglobulin AImmunoglobulin GMECA-32 antigen, mouseMembrane ProteinsMicrofilament ProteinsnephrinPhosphatidylinositol 3-KinasesPik3c2a protein, mouseSynpo protein, mouse

Identifiers

PMID20974805
PMCPMC3019860
OpenAlexW2170890869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.